Welcome to TD2’s Comprehensive Oncology Ecosystem
At TD2, we are revolutionizing oncology research through an integrated ecosystem that brings together preclinical services, advanced flow cytometry, robust regulatory support, an extensive site network, and comprehensive clinical trial services. Our mission is to accelerate the development of innovative cancer therapies.
Integrated Preclinical Services
Our preclinical services form the foundation of our oncology ecosystem. We offer extensive in vitro and in vivo capabilities to support your research from the earliest stages. Our in vitro pharmacology laboratory provides critical insights into drug potency, sensitivity, and resistance profiles. In vivo studies leverage our expansive collection PDX, orthotopic, syngeneic and humanized checkpoint inhibitor models to identify and optimize development strategies, including tumor growth inhibition, imaging endpoints, and biomarker analysis.
Advanced Flow Cytometry
Flow cytometry is a cornerstone of our preclinical and clinical research. Our state-of-the-art flow cytometry facilities enable precise evaluation of immune cell function and phenotypic characterization. This technology is pivotal in our immuno-oncology studies, particularly for adoptive cell transfer therapies like CAR-T. By using advanced fluorescent-based methods, we ensure accurate cell counting and viability assessments, enhancing the reliability of our research outcomes and clinical trial endpoints.
Robust Regulatory Support
Navigating the complex regulatory landscape is critical to the success of any therapeutic development program. TD2 provides comprehensive translational and regulatory support to ensure your research adheres to all necessary guidelines and requirements. Our experienced team works closely with sponsors to develop regulatory strategies that align with clinical and commercial goals, facilitating a smoother transition from preclinical research to clinical trials and eventual market approval.
Extensive Site Network and Engagement
Our oncology ecosystem is differentiated by a robust network of clinical trial sites. We have established strong partnerships with leading oncology centers and research institutions, along with community-based hospitals ensuring access to diverse patient populations and deep clinical expertise. This network enhances our ability to conduct efficient and effective clinical trials, from early-phase studies to pivotal late-phase trials.
Comprehensive Clinical Trial Services
TD2’s clinical trial services are designed to support every aspect of your therapeutic program. Our team of experts provides end-to-end management, from study design and site selection to patient recruitment and data analysis. We offer Phase I, II and III clinical trial management utilizing a data-driven, flexible and efficient approach. Using innovative and precise methods for capturing and analyzing data, we identify early signals of response to put your oncology therapy on the path to approval. Our commitment to transparency and communication ensures that sponsors are informed and engaged throughout the trial process.
Learn more about our Integrated Services
Contact our experts to help advance your drug development with TD2's Comprehensive Oncology Ecosystem.
TD2’s Comprehensive Oncology Ecosystem
By integrating these elements, TD2 offers a comprehensive suite of services that support the entire lifecycle of oncology drug development, ensuring that each phase is executed with the highest standards of quality and efficiency.
get started
Work with a team who believes in your research as much as you do.
Are you ready advance your oncology research with our proven, validated tumor cell lines? Partner with a collaborative oncology CRO that believes in your treatment as much as you do. Take the first step today and contact our experts.
